Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$31.15 - $33.39 $183,785 - $197,001
-5,900 Reduced 24.89%
17,800 $591,000
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $58,710 - $63,744
1,900 Added 8.72%
23,700 $747,000
Q2 2022

Aug 15, 2022

SELL
$23.75 - $31.69 $375,250 - $500,702
-15,800 Reduced 42.02%
21,800 $663,000
Q1 2022

May 16, 2022

SELL
$19.97 - $26.94 $2.04 Million - $2.75 Million
-102,000 Reduced 73.07%
37,600 $976,000
Q4 2021

Feb 14, 2022

SELL
$17.46 - $21.61 $2.75 Million - $3.41 Million
-157,600 Reduced 53.03%
139,600 $2.85 Million
Q3 2021

Nov 15, 2021

BUY
$17.35 - $22.5 $50,315 - $65,250
2,900 Added 0.99%
297,200 $5.72 Million
Q2 2021

Aug 11, 2021

BUY
$18.01 - $28.32 $457,454 - $719,328
25,400 Added 9.45%
294,300 $6.53 Million
Q1 2021

May 17, 2021

BUY
$19.76 - $29.89 $4.07 Million - $6.15 Million
205,800 Added 326.15%
268,900 $7.06 Million
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $165,165 - $227,430
-10,500 Reduced 14.27%
63,100 $1.18 Million
Q3 2020

Nov 16, 2020

BUY
$13.54 - $26.41 $643,150 - $1.25 Million
47,500 Added 181.99%
73,600 $1.25 Million
Q2 2020

Aug 14, 2020

SELL
$7.84 - $23.29 $156,800 - $465,800
-20,000 Reduced 43.38%
26,100 $608,000
Q1 2020

May 15, 2020

BUY
$5.57 - $11.5 $162,087 - $334,650
29,100 Added 171.18%
46,100 $387,000
Q4 2019

Feb 14, 2020

SELL
$7.9 - $10.14 $15,800 - $20,280
-2,000 Reduced 10.53%
17,000 $166,000
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $84,864 - $137,280
7,800 Added 69.64%
19,000 $226,000
Q3 2018

Nov 14, 2018

SELL
$14.85 - $16.35 $80,190 - $88,290
-5,400 Reduced 32.53%
11,200 $167,000
Q2 2018

Aug 14, 2018

BUY
$13.8 - $16.8 $81,420 - $99,120
5,900 Added 55.14%
16,600 $264,000
Q3 2017

Nov 14, 2017

BUY
$13.45 - $14.35 $143,915 - $153,545
10,700
10,700 $153,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.